Insider Trading29 Sept 2026, 04:09 pm
Bliss GVS Pharma Closes Trading Window from Oct 1, 2026
AI Summary
Bliss GVS Pharma Ltd has announced the closure of its trading window effective Thursday, October 01, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will remain shut for designated persons, insiders, and their immediate relatives until 48 hours after the announcement of the unaudited financial results for the quarter and half-year ended September 30, 2026. The exact date for the board meeting to declare these results will be intimated later. Insiders are advised against trading in the company's securities during this period.
Key Highlights
- Trading window closure effective October 1, 2026.
- Applies to insiders and designated persons.
- Closure until 48 hours post Q2 FY27 results announcement.
- Aims to prevent insider trading.
- Board meeting date for results to be announced later.
Price Impact
More from BLISSGVS